Skip to main content
European Commission logo
English English
CORDIS - EU research results
CORDIS
CORDIS Web 30th anniversary CORDIS Web 30th anniversary
Content archived on 2024-05-24

To explore the use of innovative biostatistical analysis in the identification of novel disease-genes

Objective

HiberGen mission is to identify 'disease-genes'. HiberGen's core competency is in the identification of gene mutations or SNPs, using a proprietary mutation detection platform technology, called SNaPIT. HiberGen has secured broad access to selected patient groups within the genetically homogenous Irish population. The application of HiberGen's SNaPIT to these patient samples will generate new genetic data. This data will require intense bio statistical analysis to identify disease linkage. And represents a core activity for HiberGen. With this Exploraty award, Hibergen will be facilitated to identify partners, with whom it can test such bio statistical systems. 'Disease-genes' represent significant value within the pharmaceutical industry as they represent new targets for the development of better diagnostic tools and improved therapeutic agents for the treatment, management and prevention of disease contributing to the community goals on many levels.

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques.

You need to log in or register to use this function

Call for proposal

Data not available

Coordinator

HIBERGEN LIMITED
EU contribution
No data
Address
Technology House, Enterprise Ireland, Glasnevin,
N/A Dublin 9
Ireland

See on map

Links
Total cost
No data

Participants (1)